These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35414777)
1. ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis. Hou R; Li Y; Luo X; Zhang W; Yang H; Zhang Y; Liu J; Liu S; Han S; Liu C; Huang Y; Liu Z; Li A; Fang W Int J Biol Sci; 2022; 18(6):2553-2567. PubMed ID: 35414777 [TBL] [Abstract][Full Text] [Related]
2. The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma. Liu JH; Yang HL; Deng ST; Hu Z; Chen WF; Yan WW; Hou RT; Li YH; Xian RT; Xie YY; Su Y; Wu LY; Xu P; Zhu ZB; Liu X; Deng YL; Wang YB; Liu Z; Fang WY Acta Pharmacol Sin; 2022 Oct; 43(10):2687-2695. PubMed ID: 35296779 [TBL] [Abstract][Full Text] [Related]
3. Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression. Hou R; Liu X; Yang H; Deng S; Cheng C; Liu J; Li Y; Zhang Y; Jiang J; Zhu Z; Su Y; Wu L; Xie Y; Li X; Li W; Liu Z; Fang W Cancer Lett; 2022 Apr; 531():57-70. PubMed ID: 35114328 [TBL] [Abstract][Full Text] [Related]
4. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma. Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025 [TBL] [Abstract][Full Text] [Related]
5. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway. Liu Y; Jiang Q; Liu X; Lin X; Tang Z; Liu C; Zhou J; Zhao M; Li X; Cheng Z; Li L; Xie Y; Liu Z; Fang W EBioMedicine; 2019 Oct; 48():386-404. PubMed ID: 31594754 [TBL] [Abstract][Full Text] [Related]
6. RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinoma. Ke S; Lu S; Xu Y; Bai M; Yu H; Yin B; Wang C; Feng Z; Li Z; Huang J; Li X; Qian B; Hua Y; Fu Y; Sun B; Wu Y; Ma Y Exp Mol Med; 2024 Jun; 56(6):1412-1425. PubMed ID: 38825640 [TBL] [Abstract][Full Text] [Related]
7. Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo. Li W; Pei S; Zhang X; Qi D; Zhang W; Dou Y; Yang R; Yao X; Zhang Z; Xie S; Fang D; Sun H Eur J Pharmacol; 2022 May; 922():174886. PubMed ID: 35292248 [TBL] [Abstract][Full Text] [Related]
8. ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9-induced deubiquitination of β-catenin to block gastric cancer metastasis. Liu J; Liu Z; Yan W; Yang H; Fang S; Deng S; Wen Y; Shen P; Li Y; Hou R; Liu X; Huang T; Li R; Zheng D; Liu Z; Fang W MedComm (2020); 2022 Dec; 3(4):e185. PubMed ID: 36448053 [TBL] [Abstract][Full Text] [Related]
9. ENKUR Is Involved in the Regulation of Cellular Biology in Colorectal Cancer Cells via PI3K/Akt Signaling Pathway. Ma Q; Lu Y; Gu Y Technol Cancer Res Treat; 2019 Jan; 18():1533033819841433. PubMed ID: 30947633 [TBL] [Abstract][Full Text] [Related]
10. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma. Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550 [TBL] [Abstract][Full Text] [Related]
11. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway. Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274 [TBL] [Abstract][Full Text] [Related]
12. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression. Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212 [TBL] [Abstract][Full Text] [Related]
13. Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling. Wang KX; Du GH; Qin XM; Gao L Phytomedicine; 2021 Dec; 93():153781. PubMed ID: 34649212 [TBL] [Abstract][Full Text] [Related]
14. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways. Han K; Li C; Zhang X; Shang L Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112 [TBL] [Abstract][Full Text] [Related]
15. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Zhang N; Chen X Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
17. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells. Wang C; Ruan P; Zhao Y; Li X; Wang J; Wu X; Liu T; Wang S; Hou J; Li W; Li Q; Li J; Dai F; Fang D; Wang C; Xie S Oncotarget; 2017 Jan; 8(1):1092-1109. PubMed ID: 27901475 [TBL] [Abstract][Full Text] [Related]
18. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes. Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133 [TBL] [Abstract][Full Text] [Related]
19. Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway. Sun L; He M; Li F; Wu D; Zheng P; Zhang C; Liu Y; Liu D; Shan M; Yang M; Ma Y; Lian J; Xiong H Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38573832 [TBL] [Abstract][Full Text] [Related]
20. Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9. Li Y; Liu X; Lin X; Zhao M; Xiao Y; Liu C; Liang Z; Lin Z; Yi R; Tang Z; Liu J; Li X; Jiang Q; Li L; Xie Y; Liu Z; Fang W Signal Transduct Target Ther; 2019; 4():48. PubMed ID: 31754475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]